FDA, Aetion To Jointly Research Real-World Evidence To Curb COVID-19

By Beth Wang / May 19, 2020 at 11:52 AM
FDA and Aetion, a health care technology company, are joining forces to study how real-world data can be used to stem the COVID-19 pandemic . The company and FDA will use Aetion's Evidence Platform to analyze fit-for-purpose data sources to characterize COVID-19 patient populations and their medication use, identify risk factors for COVID-19-related complications, and contribute to research on potential interventions, Aetion announced Tuesday (May 19). The proliferation of more than 300 potential COVID-19 treatments and vaccines in the planning...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.